Hey readers! Here's an unexpected wrinkle from this issue: going gluten-free calms the immune attack, but your gut bacteria seem to hold onto their own memory of celiac disease long after the biopsy looks better. Two fresh 2026 studies dig into exactly that, and below them you'll find a new anti-IL-15 drug update, a new adult celiac center you can actually call, a nationwide flour recall to check your pantry against, and a practical note on finding safe food. Let's get into it.
🦠 The microbiome keeps its own record
New Study Finds Gut Bacteria and Metabolic Changes in Children With Celiac Disease looked at stool from eleven children with newly diagnosed, untreated celiac disease and compared them with ten children without it, then retested most of the celiac group after six months on a gluten-free diet.
– Celiac.com
The headline finding is less about which bacteria are present and more about what they're doing. Celiac disease didn't wipe out overall microbial diversity; instead it showed up as specific shifts, especially in Bacteroides ovatus, along with changes in butyrate, amino acids, and oxidative-stress markers.
The findings suggest that looking at what gut bacteria are doing, rather than simply counting which bacteria are present, may provide important clues about celiac disease and recovery after gluten is removed from the diet.
What struck me: after six months gluten-free, antibody levels dropped in every retested child, but four still sat above the normal range, and some microbiome and metabolite differences lingered. The diet itself seemed to leave a mark too, including a rise in Bilophila wadsworthia, a bacterium that responds to dietary fat and bile changes. Recovery, in other words, is real but not instant or complete at six months.
Long-Read Metagenomic Sequencing Reveals Persistent Gut Microbiome Alterations in Children with Celiac Disease in Remission is a preprint that reaches a strikingly aligned conclusion using deeper sequencing across 21 pediatric participants in remission, active disease, and non-celiac controls.
– bioRxiv (preprint, not yet peer reviewed)
Using PacBio HiFi long-read sequencing, the team reconstructed 857 high-quality genomes and profiled bacteria down to the species and pathway level. Even in children in histologic remission on a gluten-free diet, alpha-diversity was reduced versus controls, and taxonomic and functional differences persisted.
Our findings suggest a distinct microbial ecosystem during histologic remission characterized by residual taxonomic dysbiosis and functional constraints, accompanied by adaptive remodeling that may promote mucosal healing.
Remission came with depletion of commensals like Alistipes finegoldii, Bifidobacterium longum, and Bacteroides uniformis, plus some lingering inflammation-associated taxa, while short-chain fatty acid producers were enriched and anti-inflammatory propionate metabolism ramped up. Read together with the Celiac.com study, the takeaway for clinicians and parents is consistent: a healed intestinal lining does not mean a fully reset microbiome. That gap may help explain why some kids stay symptomatic or feel off even when the numbers improve, and it's a strong argument for tracking metabolic output, not just diversity scores.
💊 Treatments and support beyond the diet
Since the gluten-free diet clearly isn't the whole story of recovery, here are the concrete places where new tools are showing up.
Teva's Lab-Made Antibody Shot for Celiac Shows Hopeful Results reports Phase 2a topline data for TEV '408, an antibody designed to block IL-15, a signaling molecule in the gut's immune response to gluten.
– Allergic Living
In the 50-adult study, participants on a gluten-free diet got the drug or placebo, then ate a gluten challenge equal to a standard slice of bread (3 grams) daily for six weeks. Teva reports lower symptom scores on the standardized Celiac Disease Symptom Diary and less intestinal damage versus placebo, and says the drug was well-tolerated.
A strict gluten-free diet has long been the only option for people living with celiac disease.
Worth keeping expectations calibrated here. Instalab's breakdown notes that treated participants showed about half as much villous-height loss as placebo, but stresses these are company-reported, interim results from a small study with no peer review or complete safety follow-up. A prior anti-IL-15 antibody, AMG 714, failed its key biopsy endpoints, and it's still unknown whether protection during a scripted challenge translates to real-world durability. Encouraging progress, not a reason to relax gluten avoidance.
– Instalab
UC Health opens center dedicated to celiac disease marks the opening of what UC Health calls the region's first comprehensive center for adults with celiac disease, non-celiac gluten sensitivity, abnormal celiac testing, and enteropathies.
– Spectrum News 1
The reason this matters is the transition gap: kids with celiac disease often lose specialized care in their late teens. Director Dr. Amanda Cartee frames it directly.
Celiac disease is something that impacts people for the rest of their lives after diagnosis, and their symptoms can change or they can develop health issues later in life.
The center offers diagnosis, dietician access, family screening, mineral monitoring, and clinical-trial access, and partners with Cincinnati Children's Celiac Disease Center on care transitions. If you're in the region, WLWT reports it's at UC Health's Montgomery Medical Office, with appointments at 513-475-7505.
– WLWT
🔬 Lab-stage leads worth watching
These are early, mostly preclinical signals. Not clinical advice, but they show where the microbiome-and-gut-lining research is heading.
Saccharomyces boulardii CNCM I-745 protects against small intestinal injury - In a gliadin-peptide mouse model, this probiotic yeast restored the villus-to-crypt ratio and reduced intraepithelial lymphocyte infiltration; the authors say clinical evaluation in celiac disease is now warranted. – GreenMedInfo
Grape seed-derived procyanidin alleviates gliadin p31–43-induced epithelial stress - A food-derived polyphenol eased gliadin-driven cell stress and improved barrier markers in cells and mice, tied to ATF4 signaling and iron homeostasis. – npj Science of Food
New clinical study expands on LPLDL efficacy in adults with celiac disease - A 9-week pilot found the probiotic strain plus plant sterols improved atherogenic lipid markers and boosted microbial diversity in adults with celiac disease and high cholesterol, a reminder that cholesterol can normalize (and stay elevated) once the diet fixes absorption. – Innovations Food
⚠️ Check your pantry: nationwide flour recall
GF Blends recalls gluten-free products flour, bread mix, pizza mix covers a nationwide recall of three products after third-party testing found gluten above the FDA's 20 parts per million limit.
– USA TODAY
The unsettling part: the plantain flour behind these products, from supplier PMF Global, was itself labeled and certified gluten-free, yet testing detected gluten in both the ingredient and the finished goods. Medical Daily's coverage names the affected items, Truly AIP All Purpose Flour, Truly AIP Bread Mix, and EAT G.A.N.G.S.T.E.R. Flat Bread Pizza Mix, sold through the brands' sites and Amazon.
– Medical Daily
For people with celiac disease, an autoimmune condition the FDA says affects as many as 3 million Americans, gluten damages the lining of the small intestine, and a gluten-free label is often their main safeguard.
Check the FDA notice for exact lot numbers and best-by dates. No illnesses were reported as of September 17, and affected buyers can return items for a refund or discard them.
🍽️ A living-gluten-free note
Recalls like this are a reminder that a label isn't a guarantee. When you're eating out or traveling and want crowd-sourced reads on how carefully a place handles cross-contact, the Find Me Gluten Free site and app is a genuinely useful resource for safe restaurants and travel options. We're not sponsored by them; it's just a tool a lot of this community leans on.
🧒 Also on the pediatric radar
Type 1 diabetes keeps showing up alongside celiac research, and the microbiome thread runs through it too.
Stalled gut microbiome development triples risk for type 1 diabetes in children - In the TEDDY Study of 887 high-risk children and more than 12,000 stool samples, an early-plateaued microbiome pattern carried about three times the risk of type 1 diabetes or the immune attack preceding it. – News-Medical
Experts recommend systematic screening of children for type 1 diabetes - A new international consensus in Diabetologia backs population-wide islet-autoantibody screening at ages 2 to 4, then 6 to 8 and 10 to 15, noting more than 85% of new cases have no family history. – EurekAlert!
Both reinforce a theme worth holding onto: early gut microbiome maturation looks increasingly tied to autoimmune risk, and combining microbiome data with genetics gives a sharper picture than either alone.
That's the issue. If one thing sticks, let it be this: gluten-free is the foundation of recovery, but the microbiome and its metabolic output are still catching up months later, and that's exactly where the next generation of tools is aiming. Take care of yourselves and each other.